Phibro Animal Health Corporation (PAHC) vs Xeris Biopharma Holdings, Inc. (XERS)
- Phibro Animal Health Corporation PAHC 38.82 +2.21%
- Xeris Biopharma Holdings, Inc. XERS 10.28 +2.09%
Phibro Animal Health Corporation and Xeris Biopharma Holdings, Inc. are both Drug Manufacturers Specialty & Generic companies. Xeris Biopharma Holdings, Inc. is the larger, with a market value of $1.8B against $1.5B — 1.2× the size. Xeris Biopharma Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Phibro Animal Health Corporation trades at 15.8×. Xeris Biopharma Holdings, Inc. grew revenue faster over the last twelve months: 36.3% against 17.1%. Phibro Animal Health Corporation has the higher net margin (6.57% vs −5.12%) and the lower return on invested capital (11.7% vs 18.9%). Across the 20 metrics below, Phibro Animal Health Corporation leads on 11 and Xeris Biopharma Holdings, Inc. on 9.
Valuation
Profitability
| Metric | PAHC | XERS | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 33.76% | 86.58% | 53.94% |
| Operating margin | 12.81% | 10.91% | 0.00% |
| Net margin | 6.57% | (5.12%) | 0.00% |
| Free cash flow margin | 0.65% | 16.60% | 0.00% |
| Return on equity | 29.72% | 118.22% | (0.40%) |
| Return on assets | 6.97% | (4.60%) | (3.32%) |
| Return on invested capital | 11.72% | 18.88% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack